N4 Pharma PLC Holding(s) in Company (6711N)
21 Mayo 2020 - 10:26AM
UK Regulatory
TIDMN4P
RNS Number : 6711N
N4 Pharma PLC
21 May 2020
21 May 2020
N4 Pharma plc
("N4 Pharma" or the "Company")
Holding in Company
N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company
developing Nuvec(R), a novel delivery system for cancer treatments
and vaccines, has been notified that Mr David Farrier's beneficial
interest in the Company's share capital remains at 12,175,510
ordinary shares in the Company, representing 8.00 per cent. of the
Company's issued share capital. Mr Farrier's holding was diluted
through a notifiable threshold as a result of the issue of new
ordinary shares in the Company pursuant to the placing announced on
13 May 2020.
Enquiries:
N4 Pharma Plc
Nigel Theobald, CEO Via Scott PR
Allenby Capital Limited Tel: +44(0)203 328 5656
James Reeve/Asha Chotai
Turner Pope Investments (TPI) Tel: +44(0)20 3657 0050
Ltd
Andrew Thacker
Scott PR Tel: +44(0)1477 539 539
Georgia Smith
About N4 Pharma
N4 Pharma is a specialist pharmaceutical company developing a
novel delivery system for cancer and vaccine treatments using its
unique silica nanoparticle delivery system called Nuvec(R).
N4 Pharma's business model is to partner with companies
developing novel antigens for cancer and vaccine treatments to use
Nuvec(R) as the delivery vehicle to get their antigen into cells to
express the protein needed for the required immunity. As these
products progress through pre clinical and clinical programs, N4
Pharma will seek to receive up front payments, milestone payments
and ultimately royalty payments once products reach the market.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
HOLFLFFEESILFII
(END) Dow Jones Newswires
May 21, 2020 11:26 ET (15:26 GMT)
N4 Pharma (LSE:N4P)
Gráfica de Acción Histórica
De Feb 2024 a Mar 2024
N4 Pharma (LSE:N4P)
Gráfica de Acción Histórica
De Mar 2023 a Mar 2024